The cardiovascular safety of oral alitretinoin. A population-based cohort study involving 19,513 patients exposed to oral alitretinoin

CONCLUSIONS: These data from an exhaustive nationwide population-based study did not support an increase in the incidence of atherothrombotic events under alitretinoin, regardless of the baseline cardiovascular risk of the patient.PMID:33735442 | DOI:10.1111/bjd.20069

Source: The British Journal of Dermatology - March 18, 2021 Category: Dermatology Authors: F Poizeau F Balusson A P Jonville-B éra E Nowak M D Drici P Y Scarabin C Droitcourt A Dupuy E Oger Source Type: research